Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Neurobiology of Aging|July 26, 2011
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's diseaseManu Sharma, Demetrius M Maraganore, John P A Ioannidis, et al.Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.Frontiers in Human Neuroscience|February 23, 2023
Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulationJoshua K Wong, Helen S Mayberg, Doris D Wang, et al.Neurology|October 19, 2014
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson diseaseJessie Theuns, Aline Verstraeten, Kristel Sleegers, et al.Neurology|July 13, 2012
Large-scale replication and heterogeneity in Parkinson disease genetic lociManu Sharma, John P A Ioannidis, Jan O Aasly, et al.Frontiers in Human Neuroscience|March 21, 2022
Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain InjuryJoshua K Wong, Günther Deuschl, Robin Wolke, et al.Neurology|September 11, 2015
Large-scale assessment of polyglutamine repeat expansions in Parkinson diseaseLisa Wang, Jan O Aasly, Grazia Annesi, et al.Neurobiology of Aging|August 22, 2013
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsMichael G Heckman, Alexis Elbaz, Alexandra I Soto-Ortolaza, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2013
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) ConsortiumMichael G Heckman, Alexandra I Soto-Ortolaza, Jan O Aasly, et al.Journal of Medical Genetics|November 6, 2012
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variantsManu Sharma, John P A Ioannidis, Jan O Aasly, et al.Pageof 13